• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在评估脱水人羊膜/绒毛膜同种异体移植物治疗静脉性腿部溃疡的疗效时,基于意向治疗和按方案分析技术的研究结果存在差异。

Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft.

机构信息

Department of Surgery, Loma Linda Veterans Affairs Healthcare System, Loma Linda, California.

Department of Medical Affairs, MiMedx Group, Inc., Marietta, Georgia.

出版信息

Int Wound J. 2019 Jun;16(3):761-767. doi: 10.1111/iwj.13094. Epub 2019 Mar 12.

DOI:10.1111/iwj.13094
PMID:30864259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6850648/
Abstract

Statistical interpretation of data collected in a randomised controlled trial (RCT) is conducted on the intention-to-treat (ITT) and/or the per-protocol (PP) study populations. ITT analysis is a comparison of treatment groups including all patients as originally allocated after randomisation regardless if treatment was initiated or completed. PP analysis is a comparison of treatment groups including only those patients who completed the treatment as originally allocated, although it is often criticised because of its potential to instil bias. A previous report from an RCT conducted to evaluate the efficacy of dehydrated human amnion/chorion membrane allograft (EpiFix) as an adjunct to standard comprehensive wound therapy consisting of moist dressings and multi-layer compression in the healing of venous leg ulcers (VLUs) only reported PP study results (n = 109, 52 EpiFix and 57 standard care patients), although there were 128 patients randomised: 64 to the EpiFix group and 64 to the standard care group. Primary study outcome was the incidence of healing at 12 weeks. The purpose of the present study is to report ITT results on all 128 randomised subjects and assess if both ITT and PP data analyses arrive at the same conclusion of the efficacy of EpiFix as a treatment for VLU. Rates of healing for the ITT and PP populations were, respectively, 50% and 60% for those receiving EpiFix and 31% and 35% for those in the standard care cohort. Within both ITT and PP analyses, these differences were statistically significant; P = 0.0473, ITT and P = 0.0128, PP. The Kaplan-Meier plot of time to heal within 12 weeks for the ITT and PP populations demonstrated a superior wound-healing trajectory for EpiFix compared with VLUs treated with standard care alone. These data provide clinicians and health policymakers an additional level of assurance regarding the effectiveness of EpiFix.

摘要

对随机对照试验(RCT)中收集的数据进行统计解释时,通常会基于意向治疗(ITT)和/或符合方案(PP)人群进行分析。ITT 分析是对治疗组的比较,包括所有随机分组后最初接受分配治疗的患者,无论是否开始或完成治疗。PP 分析是对治疗组的比较,仅包括那些完成最初分配治疗的患者,尽管它经常受到批评,因为它可能会引入偏倚。此前一项 RCT 报告评估了脱水人羊膜/绒毛膜同种异体移植物(EpiFix)作为湿性敷料和多层压缩标准综合伤口治疗的辅助治疗在静脉溃疡(VLU)愈合中的疗效,仅报告了 PP 研究结果(n=109,52 例 EpiFix 和 57 例标准护理患者),尽管有 128 例患者随机分组:64 例分入 EpiFix 组,64 例分入标准护理组。主要研究结局是 12 周时的愈合发生率。本研究旨在报告所有 128 例随机患者的 ITT 结果,并评估 ITT 和 PP 数据分析是否得出 EpiFix 治疗 VLU 疗效相同的结论。ITT 和 PP 人群中分别接受 EpiFix 治疗的患者愈合率为 50%和 60%,而接受标准护理的患者愈合率为 31%和 35%。在 ITT 和 PP 分析中,这些差异均具有统计学意义;P=0.0473,ITT 和 P=0.0128,PP。ITT 和 PP 人群中 12 周内愈合的 Kaplan-Meier 图显示,与单独接受标准护理治疗的 VLUs 相比,EpiFix 具有更好的伤口愈合轨迹。这些数据为临床医生和卫生政策制定者提供了关于 EpiFix 有效性的额外保证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/686d/7948877/1c2d55c17697/IWJ-16-761-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/686d/7948877/3d4ee860b408/IWJ-16-761-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/686d/7948877/1c2d55c17697/IWJ-16-761-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/686d/7948877/3d4ee860b408/IWJ-16-761-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/686d/7948877/1c2d55c17697/IWJ-16-761-g002.jpg

相似文献

1
Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft.在评估脱水人羊膜/绒毛膜同种异体移植物治疗静脉性腿部溃疡的疗效时,基于意向治疗和按方案分析技术的研究结果存在差异。
Int Wound J. 2019 Jun;16(3):761-767. doi: 10.1111/iwj.13094. Epub 2019 Mar 12.
2
A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix ) allograft for the treatment of venous leg ulcers.一项多中心随机对照试验,评估脱水人羊膜/绒毛膜(EpiFix)同种异体移植物治疗静脉性腿部溃疡的疗效。
Int Wound J. 2018 Feb;15(1):114-122. doi: 10.1111/iwj.12843. Epub 2017 Oct 11.
3
A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.脱水人羊膜/绒毛膜同种异体移植物 dHACM 在糖尿病足溃疡管理中的疗效的确证性研究:来自 14 个伤口诊所的 110 例患者的前瞻性、多中心、随机、对照研究。
Int Wound J. 2019 Feb;16(1):19-29. doi: 10.1111/iwj.12976. Epub 2018 Aug 22.
4
Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.采用先进疗法治疗慢性糖尿病下肢溃疡:一项前瞻性、随机、对照、多中心比较研究,考察临床疗效和成本。
Int Wound J. 2016 Apr;13(2):272-82. doi: 10.1111/iwj.12566. Epub 2015 Dec 23.
5
A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.一项关于使用脱水人羊膜/绒毛膜同种异体移植、生物工程皮肤替代物或慢性下肢糖尿病溃疡治疗的护理标准进行愈合的前瞻性、随机、对照、多中心比较有效性研究。
Int Wound J. 2015 Dec;12(6):724-32. doi: 10.1111/iwj.12395. Epub 2014 Nov 26.
6
A multicenter, randomized, controlled clinical trial evaluating the use of dehydrated human amnion/chorion membrane allografts and multilayer compression therapy vs. multilayer compression therapy alone in the treatment of venous leg ulcers.一项多中心、随机、对照临床试验,评估使用脱水人羊膜/绒毛膜同种异体移植物与多层压迫疗法联合治疗与单独使用多层压迫疗法治疗下肢静脉溃疡的效果。
Wound Repair Regen. 2014 Nov-Dec;22(6):688-93. doi: 10.1111/wrr.12227. Epub 2015 Jan 8.
7
A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers.前瞻性随机对照平行研究羊膜创面移植物在糖尿病足溃疡治疗中的应用。
Int Wound J. 2013 Oct;10(5):502-7. doi: 10.1111/iwj.12097. Epub 2013 Jun 7.
8
Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.脱水羊膜绒毛膜与糖尿病足溃疡的标准治疗比较:一项随机对照试验。
J Wound Care. 2024 Jul 1;33(Sup7):S4-S14. doi: 10.12968/jowc.2024.0139. Epub 2024 Jun 6.
9
Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.使用无菌处理的脱水人羊膜和绒毛膜可提高慢性糖尿病足溃疡的愈合可能性和速度:80 例患者的前瞻性、随机、多中心临床试验。
Int Wound J. 2018 Dec;15(6):950-957. doi: 10.1111/iwj.12954. Epub 2018 Jul 17.
10
Potential cost-effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non-healing diabetic foot ulcers in the United Kingdom.英国使用辅助脱水人羊膜/绒毛膜移植物治疗不愈合的糖尿病足溃疡的潜在成本效益。
Int Wound J. 2021 Dec;18(6):889-901. doi: 10.1111/iwj.13591. Epub 2021 Apr 7.

引用本文的文献

1
Assessing the Safety, Tolerability and Efficacy of Cell-Free Amniotic Fluid in the Treatment of Non-Healing Venous Ulcers: Initial Experience From a Prospective, Multicenter, Phase II Study.评估无细胞羊水治疗难愈合静脉溃疡的安全性、耐受性和疗效:一项前瞻性、多中心、II期研究的初步经验
Int Wound J. 2025 Apr;22(4):e70171. doi: 10.1111/iwj.70171.
2
Amnion-derived hydrogels as a versatile platform for regenerative therapy: from lab to market.羊膜来源的水凝胶作为再生治疗的通用平台:从实验室到市场。
Front Bioeng Biotechnol. 2024 Feb 26;12:1358977. doi: 10.3389/fbioe.2024.1358977. eCollection 2024.
3
Placental-Derived Biomaterials and Their Application to Wound Healing: A Review.

本文引用的文献

1
A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix ) allograft for the treatment of venous leg ulcers.一项多中心随机对照试验,评估脱水人羊膜/绒毛膜(EpiFix)同种异体移植物治疗静脉性腿部溃疡的疗效。
Int Wound J. 2018 Feb;15(1):114-122. doi: 10.1111/iwj.12843. Epub 2017 Oct 11.
2
Common pitfalls in statistical analysis: Intention-to-treat versus per-protocol analysis.统计分析中的常见陷阱:意向性分析与符合方案分析。
Perspect Clin Res. 2016 Jul-Sep;7(3):144-6. doi: 10.4103/2229-3485.184823.
3
Assessing the Gold Standard--Lessons from the History of RCTs.
胎盘衍生生物材料及其在伤口愈合中的应用:综述
Bioengineering (Basel). 2023 Jul 12;10(7):829. doi: 10.3390/bioengineering10070829.
4
Comparison of Skin Substitutes for Acute and Chronic Wound Management.用于急性和慢性伤口处理的皮肤替代物比较
Semin Plast Surg. 2021 Aug;35(3):171-180. doi: 10.1055/s-0041-1731463. Epub 2021 Sep 10.
5
Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.成人糖尿病足溃疡和静脉性腿部溃疡用皮肤替代品:一项卫生技术评估。
Ont Health Technol Assess Ser. 2021 Jun 4;21(7):1-165. eCollection 2021.
6
Potential cost-effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non-healing diabetic foot ulcers in the United Kingdom.英国使用辅助脱水人羊膜/绒毛膜移植物治疗不愈合的糖尿病足溃疡的潜在成本效益。
Int Wound J. 2021 Dec;18(6):889-901. doi: 10.1111/iwj.13591. Epub 2021 Apr 7.
7
Strategies and challenges in the treatment of chronic venous leg ulcers.下肢慢性静脉溃疡治疗中的策略与挑战
World J Clin Cases. 2020 Nov 6;8(21):5070-5085. doi: 10.12998/wjcc.v8.i21.5070.
8
LOXL2 from human amniotic mesenchymal stem cells accelerates wound epithelialization by promoting differentiation and migration of keratinocytes.人羊膜间充质干细胞来源的 LOXL2 通过促进角质形成细胞的分化和迁移加速创面上皮化。
Aging (Albany NY). 2020 Jul 4;12(13):12960-12986. doi: 10.18632/aging.103384.
9
Diabetic Foot Ulcers: Appraising Standard of Care and Reviewing New Trends in Management.糖尿病足溃疡:评估标准护理并综述管理新趋势。
Am J Clin Dermatol. 2020 Apr;21(2):255-264. doi: 10.1007/s40257-019-00495-x.
评估金标准——随机对照试验历史的教训
N Engl J Med. 2016 Jun 2;374(22):2175-81. doi: 10.1056/NEJMms1604593.
4
Conflict of interest in medical journals.医学期刊中的利益冲突。
Aust Prescr. 2015 Feb;38(1):2-3. doi: 10.18773/austprescr.2015.001. Epub 2015 Feb 2.
5
Wound Care Outcomes and Associated Cost Among Patients Treated in US Outpatient Wound Centers: Data From the US Wound Registry.美国门诊伤口护理中心患者的伤口护理结果及相关费用:来自美国伤口登记处的数据。
Wounds. 2012 Jan;24(1):10-7.
6
Intention-to-treat concept: A review.意向性治疗概念:综述
Perspect Clin Res. 2011 Jul;2(3):109-12. doi: 10.4103/2229-3485.83221.
7
An overview of randomization techniques: An unbiased assessment of outcome in clinical research.随机化技术概述:临床研究中对结果的无偏评估。
J Hum Reprod Sci. 2011 Jan;4(1):8-11. doi: 10.4103/0974-1208.82352.
8
Identifying and avoiding bias in research.识别和避免研究中的偏见。
Plast Reconstr Surg. 2010 Aug;126(2):619-625. doi: 10.1097/PRS.0b013e3181de24bc.
9
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.CONSORT 2010 声明:平行组随机试验报告的更新指南。
PLoS Med. 2010 Mar 24;7(3):e1000251. doi: 10.1371/journal.pmed.1000251.
10
Bias in clinical intervention research.临床干预研究中的偏倚
Am J Epidemiol. 2006 Mar 15;163(6):493-501. doi: 10.1093/aje/kwj069. Epub 2006 Jan 27.